Vertex Pharmaceuticals

Vertex Pharmaceuticals is a global biotechnology company that discovers, develops and commercialises medicines for serious diseases, with a particular focus on specialty markets. Founded in 1989, the company is headquartered in Boston's Innovation District and operates worldwide. It is a Fortune 500 company.

Its best-known work is in cystic fibrosis, where it produces breakthrough treatments. Beyond that, Vertex has therapies in development across a range of disease areas, including cancer, inflammatory bowel disease, autoimmune disorders and neurological conditions. Its activities span the full arc of the pharmaceutical business: drug discovery, drug development, scientific research and the commercialisation of therapies.

The company describes its culture as one of scientific excellence and collaboration. It encourages creativity, rigorous inquiry and bold thinking, and holds that the best ideas emerge when talented people work together. The stated mission is to translate scientific discoveries into real-world treatments that transform patients' lives.